Key statistics
On Friday, Immatics NV (4A3:DUS) closed at 8.97, 31.64% above the 52 week low of 6.81 set on Oct 31, 2023.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 8.70 |
---|---|
High | 9.04 |
Low | 8.70 |
Bid | 9.01 |
Offer | 9.17 |
Previous close | 8.74 |
Average volume | 1.23k |
---|---|
Shares outstanding | 135.61m |
Free float | 101.06m |
P/E (TTM) | -- |
Market cap | 1.34bn USD |
EPS (TTM) | -0.9042 USD |
Data delayed at least 15 minutes, as of Oct 18 2024 18:32 BST.
More ▼
Announcements
- Immatics Announces Pricing of $150 Million Public Offering
- Immatics Announces Proposed $150 Million Public Offering
- Immatics Announces Updated Phase 1b Clinical Data on ACTengine® IMA203 TCR-T Targeting PRAME in Melanoma Patients and Provides Update on Upcoming SUPRAME Phase 3 Trial
- Immatics Announces Upcoming Oral and Poster Presentations at the Society for Immunotherapy of Cancer Annual Meeting 2024
- Immatics Presents Clinical Proof-of-Concept Data from Ongoing Phase 1 Dose Escalation Trial with TCR Bispecific Molecule TCER® IMA401 Targeting MAGEA4/8 at ESMO 2024 and Provides Development Update
- Immatics Announces Upcoming Oral Presentation at the Society for Melanoma Research Congress 2024
- Immatics Announces Second Quarter 2024 Financial Results and Business Update
- Immatics Appoints Alise Reicin to Board of Directors
- Immatics Announces Upcoming Oral Presentation at ESMO Congress 2024
- Immatics Announces First Quarter 2024 Financial Results and Business Update
More ▼